|Bid||0.025 x 0|
|Ask||0.026 x 0|
|Day's Range||0.026 - 0.026|
|52 Week Range||0.022 - 0.054|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar 1, 2016 - Mar 5, 2016|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
MELBOURNE, AUSTRALIA / ACCESSWIRE / February 28, 2018 / Antisense Therapeutics ("ANP" or the "Company") (ASX: ANP; OTC PINK: ATHJF) is pleased to advise that the Company has received ...
When Antisense Therapeutics Limited (ASX:ANP) released its most recent earnings update (30 June 2017), I compared it against two factor: its historical earnings track record, and the performance of itsRead More...
Zero-debt allows substantial financial flexibility, especially for small-cap companies like Antisense Therapeutics Limited (ASX:ANP), as the company does not have to adhere to strict debt covenants. However, it also facesRead More...
Antisense Therapeutics Limited (ASX:ANP), a AUDA$5.17M small-cap, operates in the healthcare industry, which continues to endure a more demanding healthcare agenda, and the global need for innovative, cost-effective medicines continuesRead More...